On October 15, 2009
Roche Developing a “Hedgehog Inhibitor” for Cancer
Roche has a “hedgehog inhibitor” in Phase 2 of development, according to an investor presentation that accompanied its Q3 2009 results. Don’t panic. This is not a substance intended to kill the spiny-but-adorable endangered species native to the hedgerows of Europe. Rather, it’s a new therapy for basal cell carcinoma in colorectal and ovarian cancer.
0 Comments